SEC 13F Intelligence

Assenagon Asset Management S.A. / UTH

Assenagon Asset Management S.A.’s United Therapeutics Corp Del Position

Does Assenagon Asset Management S.A. own United Therapeutics Corp Del (UTH)? Yes — 84.5K shares worth $46M (+0.06% of its 13F portfolio) as of Q2 2026, up from 47.2K shares the prior filed quarter.

Position Value
$46M
Q2 2026
Shares
84.5K
% of Portfolio
+0.06%
Quarters Held
27
currently held

Position History UTH

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $4MQ2 ’19: $3MQ2 ’20: $3MQ3 ’20: $880,000Q3 ’20Q1 ’21: $26MQ2 ’21: $68MQ3 ’21: $8MQ4 ’21: $2MQ4 ’21Q1 ’22: $38MQ2 ’22: $151MQ3 ’22: $128MQ4 ’22: $167,342Q4 ’22Q1 ’23: $149MQ2 ’23: $108MQ3 ’23: $20MQ4 ’23: $17MQ4 ’23Q1 ’24: $19MQ2 ’24: $29MQ3 ’24: $23MQ4 ’24: $19MQ4 ’24Q1 ’25: $20MQ2 ’25: $10MQ3 ’25: $9MQ4 ’25: $12MQ4 ’25Q1 ’26: $28MQ2 ’26: $46Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202684.5K$46M+0.06%
Q1 202647.2K$28M+0.04%
Q4 202524.6K$12M+0.02%
Q3 202520.8K$9M+0.01%
Q2 202534.0K$10M+0.01%
Q1 202565.4K$20M+0.03%
Q4 202455.1K$19M+0.03%
Q3 202463.2K$23M+0.04%
Q2 202490.6K$29M+0.06%
Q1 202480.9K$19M+0.04%
Q4 202378.0K$17M+0.05%
Q3 202389.1K$20M+0.06%
Q2 2023488.2K$108M+0.37%
Q1 2023665.6K$149M+0.53%
Q4 2022601.8K$167,342+0.60%
Q3 2022613.3K$128M+0.49%
Q2 2022641.7K$151M+0.56%
Q1 2022209.9K$38M+0.10%
Q4 202111.2K$2M+0.01%
Q3 202144.2K$8M+0.03%
Q2 2021379.0K$68M+0.23%
Q1 2021158.2K$26M+0.11%
Q3 20208.7K$880,0000.00%
Q2 202027.6K$3M+0.02%
Q2 201935.8K$3M+0.02%
Q1 201930.4K$4M+0.03%
Q4 201827.0K$3M+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of UTH.